Care.fi ने जुटाए 8 करोड़ रुपये का ऋण पूंजी, Wint Wealth और Caspian से मिला समर्थन

हेल्थकेयर-फोकस्ड फिनटेक स्टार्टअप Care.fi ने 8 करोड़ रुपये की ऋण पूंजी जुटाई है। इसमें से 5 करोड़ रुपये Wint Wealth से और 3 करोड़ रुपये Caspian से इम्पैक्ट डेब्ट के रूप में प्राप्त हुए हैं। यह कंपनी के लिए एक महत्वपूर्ण वित्तीय समर्थन है, जिसका उपयोग वह अपने हेल्थकेयर फाइनेंसिंग समाधानों को और भी व्यापक रूप से लागू करने में करेगी।

पिछली पूंजी जुटाने की उपलब्धियां
Care.fi ने इससे पहले भी ऋण पूंजी के रूप में $2 मिलियन (लगभग 16 करोड़ रुपये) जुटाए थे, जो Trifecta Capital से प्राप्त हुए थे। इसके अलावा, तीन महीने पहले कंपनी ने UC Inclusive Credit से $0.6 मिलियन (लगभग 5 करोड़ रुपये) की अतिरिक्त पूंजी भी जुटाई थी। इस तरह के वित्तीय समर्थन ने कंपनी को अपने बिजनेस मॉडल को स्थिरता प्रदान करने और अपने उत्पादों और सेवाओं को और विस्तारित करने का मौका दिया है।

कंपनी के बारे में

Care.fi एक हेल्थकेयर फिनटेक स्टार्टअप है, जो हेल्थकेयर इंडस्ट्री में फाइनेंसिंग समाधानों पर ध्यान केंद्रित करता है। इसका मुख्य उद्देश्य हेल्थकेयर से जुड़ी वित्तीय समस्याओं का समाधान करना है और मरीजों और हेल्थकेयर प्रदाताओं के बीच वित्तीय असंतुलन को दूर करना है। कंपनी टेक्नोलॉजी का उपयोग करके हेल्थकेयर खर्चों को और भी सुगम और सुलभ बनाने का काम कर रही है।

संस्थापकों के बारे में

Care.fi की स्थापना गुरुग्राम में हुई थी, और इसके संस्थापक टीम में विभिन्न फिनटेक और हेल्थकेयर इंडस्ट्री के अनुभवी लोग शामिल हैं। संस्थापकों ने हेल्थकेयर क्षेत्र में काम करते हुए फाइनेंसिंग समस्याओं को नजदीक से देखा और इस समाधान को विकसित करने का निर्णय लिया। उनकी यह दृष्टि है कि वे हेल्थकेयर फाइनेंसिंग को और भी सुलभ बनाएं, जिससे मरीजों को इलाज में आर्थिक परेशानियों का सामना न करना पड़े।

कंपनी का वित्तीय प्रदर्शन

Care.fi के वित्तीय प्रदर्शन को देखा जाए तो यह कंपनी ने हाल ही में ऋण पूंजी के रूप में काफी सफलता प्राप्त की है। Trifecta Capital और UC Inclusive Credit जैसे बड़े नामों से वित्तीय समर्थन प्राप्त करना कंपनी की बाजार में अच्छी स्थिति को दर्शाता है। कंपनी का प्रमुख उद्देश्य यह है कि वह अपने हेल्थकेयर फाइनेंसिंग समाधानों को और अधिक व्यापक बनाए, जिससे मरीजों को बेहतर वित्तीय समाधान मिल सके।

Care.fi का उद्देश्य

Care.fi का लक्ष्य है कि वह हेल्थकेयर इंडस्ट्री में एक महत्वपूर्ण खिलाड़ी बने। इसका ध्यान खासकर उन क्षेत्रों में है जहां हेल्थकेयर फाइनेंसिंग की आवश्यकता सबसे ज्यादा होती है। कंपनी यह सुनिश्चित करना चाहती है कि मरीजों को आर्थिक संकट के कारण जरूरी इलाज से वंचित न होना पड़े।

भविष्य की योजनाएं

इस नई पूंजी के साथ, Care.fi अपने उत्पादों और सेवाओं का विस्तार करने के साथ-साथ नए मार्केट्स में भी प्रवेश करने की योजना बना रही है। कंपनी का मानना है कि वित्तीय समाधान प्रदान करने के इस अनूठे दृष्टिकोण से वे हेल्थकेयर इंडस्ट्री में एक नई क्रांति ला सकते हैं। इसके साथ ही वे अपने टेक्नोलॉजी प्लेटफार्म को भी और मजबूत बनाने की दिशा में काम कर रहे हैं।

निष्कर्ष

Care.fi की यह नई पूंजी जुटाने की उपलब्धि कंपनी के लिए एक महत्वपूर्ण कदम है। यह दिखाता है कि निवेशक हेल्थकेयर फाइनेंसिंग के इस नए मॉडल में संभावनाएं देख रहे हैं। कंपनी का मुख्य ध्यान वित्तीय समाधान प्रदान करके हेल्थकेयर सेक्टर को और मजबूत बनाने पर है।

Sharang Shakti Secures Rs 5 Crore in Pre-Seed Funding to Revolutionize Defense Robotics

Sharang Shakti, a defense robotics startup based in Gurugram, has successfully raised Rs 5 crore in a pre-seed funding round. This round was co-led by AUM Ventures and Venture Highway, with additional participation from the JK Group’s Family Office and several angel investors. The funds will be used to fuel product development and expand the company’s team, according to their press release.

Innovating Defense Robotics

Founded in 2023 by a talented team including Karan Goyal, Chirag Singla, Jitendra Singh, Gaurav Kumar, and Rishabh Choudhary, Sharang Shakti focuses on creating advanced security robotics. Their goal is to innovate in the fields of airspace surveillance and airborne threat mitigation.

The company’s flagship project is an anti-drone system, which is designed to detect, track, and neutralize hostile drones. This cutting-edge technology aims to address growing security threats posed by rogue drones. The anti-drone system is just the beginning, as the company has several other products in the development pipeline.

For more insights into airspace surveillance and robotic defense solutions, check out the latest developments in the global defense robotics industry.

A Growing Market for Defense Robotics

According to market research, the global Anduril industry, which focuses on defense and security technologies, is valued at around $14 billion. This highlights the immense potential for Sharang Shakti to tap into a fast-growing industry and make a significant impact.

The company’s vision is to build a comprehensive technology stack that will enable the development of a wide range of robotic systems for defense applications. Their long-term goal is to position themselves as the “next-gen Lockheed Martin” from India, setting new benchmarks in the defense sector.

Building a Strong Team and Product Line

With this recent funding, Sharang Shakti plans to expand its team and accelerate the development of its anti-drone system. The company aims to bring together the best minds in robotics, AI, and defense technology to create solutions that can effectively safeguard national security.

The proceeds will also support the development of future products in the company’s pipeline, all of which focus on enhancing airspace security and mitigating airborne threats.

Defense Tech Initiatives in India

The rise of defense technology startups like Sharang Shakti reflects a growing interest in the deep-tech defense sector in India. Earlier this month, IndusBridge Ventures, a defense technology-focused company, teamed up with the US-based deep-tech venture builder FedTech to launch the I2A Launchpad program. This initiative aims to support Indian dual-use startups, providing them with the resources and mentorship needed to grow.

For more information on defense startups and the I2A Launchpad program, visit IndusBridge Ventures.

Conclusion

With Rs 5 crore in fresh funding, Sharang Shakti is set to advance its anti-drone technology and expand its team to meet the growing demand for airspace security solutions. The company’s innovative approach and strategic backing position it to become a key player in India’s burgeoning defense robotics sector.

Stay updated on the latest in defense robotics by following Sharang Shakti’s journey.

Epica International Secures $18M to Boost Medical Imaging and Robotics

Epica International, a Landrum, SC-based leader in advanced medical imaging and precision robotics, has successfully secured an $18 million growth capital loan. This new funding will help the company expand its business and develop new technologies for healthcare and manufacturing.

Key Details of the Funding

The loan was provided by Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P., both of which are part of the Avenue Capital Group. The initial $13.5 million of the loan will be used to refinance Epica’s existing debt and support the company’s growth. This includes expanding its operations and accelerating research and development. An additional $4.5 million is available, depending on the achievement of specific performance milestones.

The loan agreement spans four years and also includes a provision for Avenue Capital to receive a 0.5% equity stake in Epica International. Avenue Capital also has the option to invest an additional $2 million in equity over the next two years. Additionally, Avenue can convert up to $3.5 million of their loan into common stock at a price of $8.50 per share.

Epica’s Role in Healthcare and Robotics

Epica International, led by CEO Joe Soto, is known for its advanced medical imaging and precision robotics technologies. These technologies are widely used in both human and animal healthcare, as well as in scientific research. Epica’s patented medical imaging tools enable clinicians to achieve higher accuracy, leading to better outcomes for patients. These tools are also helpful in research, allowing scientists to work with more precise data.

Epica’s robotics division focuses on creating robotic solutions that help streamline manufacturing processes. These robots enhance production quality by combining precision engineering with advanced automation, which leads to higher efficiency and accuracy in manufacturing. This technology is used across a range of industries, helping businesses improve their production lines.

Patents and Innovations

Epica International currently holds 75 patents, with more pending, for its innovative medical imaging and robotics platforms. These patents are recognized not only in the U.S. but also in the European Union and other countries. This intellectual property highlights the company’s commitment to leading in both the healthcare and robotics fields.

Future Plans

With this new funding, Epica is set to grow its impact in the medical imaging and robotics industries. The growth capital will enable the company to continue developing its cutting-edge technology and expand into new markets. The additional capital available through the loan will be used for further advancements as the company hits key milestones.

Epica’s innovations in both healthcare and industrial robotics are expected to revolutionize these sectors. By continuing to develop technologies that enhance accuracy and efficiency, the company is well-positioned to drive positive change in both human and animal healthcare, as well as in manufacturing processes.

For more information about Epica International’s groundbreaking technologies and future developments, visit their website.

Battolyser Systems Secures €30M in Series A Funding to Advance Green Hydrogen Technology

Rotterdam-based Battolyser Systems has raised €30 million in Series A funding to scale its operations and bring its next-generation electrolyser to market by 2025. The funding round was backed by Global Cleantech Capital, Innovation Industries, and Invest-NL. This investment will help the company expand and further develop its innovative technology, which aims to revolutionize the production of green hydrogen.

A New Solution for Green Hydrogen Production

Battolyser Systems, led by CEO Mattijs Slee, has developed a groundbreaking device known as the “Battolyser.” This integrated battery and electrolyser can store electricity and produce hydrogen from renewable power sources. The ability to switch on and off quickly allows the Battolyser to balance energy supply and demand, making it highly efficient in supporting renewable energy grids. This flexibility helps reduce the cost of green hydrogen and eases grid congestion.

The Battolyser is available in a 2.5 MW plug-and-play format, as well as 5 MW modules, which can be installed with additional components on-site. This versatility makes it suitable for a wide range of applications, helping industries and communities transition to cleaner energy.

Scaling Up for 2025 Launch

The new funding will enable Battolyser Systems to scale up its production and prepare for the launch of its next-generation electrolyser in 2025. This will play a crucial role in making green hydrogen more accessible and affordable. The company is focused on leveraging renewable energy to produce hydrogen, which is expected to be a key component in reducing carbon emissions and meeting global climate goals.

Additional Support from the European Investment Bank

In addition to the €30 million raised in Series A funding, Battolyser Systems previously secured €40 million in financing from the European Investment Bank (EIB) in October 2023. This combined support will allow the company to accelerate its growth and bring its innovative technology to the market more quickly.

The EIB’s involvement underscores the importance of green hydrogen in Europe’s transition to a low-carbon future. With this significant financial backing, Battolyser Systems is well-positioned to lead the way in hydrogen production and renewable energy storage .

The Importance of Green Hydrogen

Green hydrogen, produced from renewable energy sources like wind and solar, is a critical solution for reducing carbon emissions in sectors that are difficult to decarbonize, such as heavy industry and transportation. By producing hydrogen using renewable energy, Battolyser Systems is helping to create a more sustainable energy future.

With the flexibility and efficiency of its Battolyser technology, the company is poised to make a significant impact on the green hydrogen market. The ability to store and produce hydrogen on demand makes it an ideal solution for addressing the challenges of intermittent renewable energy sources.

Looking Ahead

Battolyser Systems’ next-generation electrolyser is set to hit the market in 2025, and the company is already making strides toward scaling up its operations. With the support of its investors and the European Investment Bank, the company is on track to make green hydrogen a more viable and cost-effective energy solution for industries worldwide .

AltiusHub Secures $2.25M Seed Funding to Enhance Supply Chain Visibility

Manufacturing supply chain visibility software AltiusHub has raised $2.25 million in seed funding, led by Endiya Partners with participation from other investors. The funds will be used to strengthen its engineering team and hire industry-specific senior talent.

Founded in 2023 by Siddharth Reddy and Abiram Vijaykumar, AltiusHub aims to help manufacturing companies, particularly in the pharmaceutical sector, secure their supply chains. The company’s SaaS platform enables pharmaceutical firms to track and trace products throughout the production process, ensuring compliance with global regulatory standards such as US DSCSA, EU FMD, UAE Tatmeen, and India’s iVeda.

AltiusHub’s software focuses on preventing counterfeit medicines from entering the supply chain by providing real-time visibility into the movement of products. It detects patterns and anomalies that may indicate counterfeit activities, and alerts users immediately of any irregularities or deviations, allowing for quick intervention.

The startup’s focus on the pharmaceutical industry comes at a crucial time, as counterfeiting remains a significant issue worldwide. The platform’s advanced tracking and tracing capabilities are expected to enhance product integrity and safety across the supply chain.

With the global track and trace market projected to reach $7.3 billion by 2026, AltiusHub is well-positioned to capitalize on the growing demand for secure and transparent supply chains. The new funding will further support its mission to help manufacturers safeguard their supply chains and meet regulatory compliance.